THE EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY - IRELAND COMPANY LIMITED BY GUARANTEE

Their core work

EASO is the leading European professional association dedicated to obesity science, clinical practice, and policy. They represent obesity researchers, clinicians, and patient advocates across Europe, working to improve prevention, diagnosis, and treatment of obesity as a chronic disease. In H2020 projects, they contribute domain expertise on obesity phenotyping, patient engagement, and translating nutritional and clinical research into practical treatment strategies. Their role bridges the gap between clinical obesity research and real-world patient outcomes.

What they specialise in

How they've shifted over time

EASO's early H2020 involvement (2018) centred on broad preventive health — personalised nutrition, physical activity, and general wellbeing through the PROTEIN project. From 2020 onward, their focus sharpened dramatically toward clinical obesity as a complex chronic condition, with emphasis on treatment algorithms, phenotype stratification, pharmaco-epidemiology, and digital health tools. This shift reflects the wider medical field's move from lifestyle-based obesity prevention toward precision medicine and data-driven treatment personalisation.

EASO is moving toward data-driven, algorithm-based treatment personalisation for obesity and its comorbidities, making them a strong partner for projects combining clinical obesity expertise with digital health and AI.

How they like to work

EASO participates exclusively as a consortium partner, never as coordinator — consistent with their role as a professional association contributing domain expertise rather than leading technical research. With 78 unique partners across 23 countries from just 3 projects, they operate in large, multi-national consortia typical of health-focused Research and Innovation Actions. This broad network makes them a well-connected entry point into European obesity and nutrition research communities.

Despite only 3 projects, EASO has built an extensive network of 78 partners across 23 countries, reflecting their position as a pan-European association that connects researchers, clinicians, and patient groups. Their reach spans nearly all EU member states, making them a strong networking node for health consortia.

What sets them apart

EASO is not a university or research institute — it is the representative voice of the European obesity research and clinical community. This gives them unique value as a consortium partner: they bring patient advocacy networks, clinical practice guidelines influence, and access to a continent-wide membership of obesity specialists. For any project needing legitimacy, dissemination reach, or clinical advisory input on obesity-related topics, EASO is a natural choice.

Highlights from their portfolio

• PROTEIN
  Largest funding (EUR 312,750) and earliest project, focused on personalised nutrition — shows EASO's capacity to contribute substantially beyond advisory roles.
• SOPHIA
  Directly aligned with EASO's core mission of obesity treatment optimisation, featuring federated databases and treatment algorithms that represent their strategic direction.
• TIMESPAN
  Unusual cross-domain project linking ADHD with cardiometabolic disease, signalling EASO's willingness to explore obesity comorbidities beyond traditional boundaries.